Intas may acquire poultry drug unit
Intas Pharmaceuticals Ltd is set to acquire a poultry
drug manufacturing unit for its animal healthcare division Neovet.
Intas is a major player in the Indian pharmaceutial industry manufacturing
drugs for livestock and in companion animal segment. The company is now looking
at consolidating its animal healthcare business as it is considering the
acquisition of a drug manufacturing unit in the poultry segment.
â€œWe are keen to acquire units that are into poultry drug manufacture,â€ said
Vijay Teng, vice president, Neovet, adding that the acquisition would be between
Rs 30 crore and 40 crore for the poultry segment.
The company has, until now, not entered the poultry drug segment as the
poultry sector is a highly price-sensitive sector. According to Teng, with the
improvement of the sector, it is more stable in terms of drug price.
To comment, login here
Or register to be able to comment.